X4 Pharmaceuticals Inc (NAS:XFOR)
$ 0.9532 0.0501 (5.55%) Market Cap: 160.07 Mil Enterprise Value: 129.24 Mil PE Ratio: 0 PB Ratio: 95.32 GF Score: 37/100

Q4 2019 X4 Pharmaceuticals Inc Earnings Call Transcript

Mar 12, 2020 / 12:30PM GMT
Release Date Price: $8.13 (-5.24%)
Operator

Greetings and welcome to X4 Pharmaceuticals Fourth Quarter and Full Year 2019 Business Highlights and Financial Results Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.

It is now my pleasure to introduce your host, Candice Ellis, Director of Corporate Communications and Investor Relations at X4. You may begin.

Candice Ellis
X4 Pharmaceuticals - Director of Corporate Communications & IR

Thank you, Kevin, and good morning everyone. Thanks so much for joining us as we provide a recap of our key activities during 2019 and discuss our strategy and upcoming milestones for 2020.

Presenting on today's call will be our Chief Executive Officer, Dr. Paula Ragan; our Chief Medical Officer, Dr. Lynne Kelley; and our Chief Financial Officer, Adam Mostafa. Following prepared remarks by each, we will open the call to your questions.

As a reminder on today's call, we will be making forward-looking statements regarding our regulatory and product development plans as well as our research activities.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot